Cargando…
Further Clinical Validation of the Walking Impairment Questionnaire for Classification of Walking Performance in Patients with Peripheral Artery Disease
The purpose of this study was to further validate the Walking Impairment Questionnaire (WIQ) as a self-report tool to aid in the clinical identification of walking ability of patients with peripheral artery disease (PAD). 132 patients with PAD and an ankle brachial index (ABI) ≤0.90 were enrolled; 1...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419442/ https://www.ncbi.nlm.nih.gov/pubmed/22919494 http://dx.doi.org/10.1155/2012/190641 |
_version_ | 1782240730424541184 |
---|---|
author | Sagar, S. P. Brown, P. M. Zelt, D. T. Pickett, W. L. Tranmer, J. E. |
author_facet | Sagar, S. P. Brown, P. M. Zelt, D. T. Pickett, W. L. Tranmer, J. E. |
author_sort | Sagar, S. P. |
collection | PubMed |
description | The purpose of this study was to further validate the Walking Impairment Questionnaire (WIQ) as a self-report tool to aid in the clinical identification of walking ability of patients with peripheral artery disease (PAD). 132 patients with PAD and an ankle brachial index (ABI) ≤0.90 were enrolled; 123 provided complete data for the WIQ and standardized graded treadmill test. The WIQ scores were consistent with reported scores in other studies. The absolute claudication distance (ACD) ranged from 42.3 to 1589.2 meters; the peak walking time (PWT) ranged from 68 to 1800 seconds. Adjusted WIQ scores were positively and moderately associated with the log transformed ACD and PWT (r > .53, P < .001). Based on the area under the curve analysis, an overall WIQ score of 42.5 or less identified low performers (sensitivity 0.90, specificity 0.73); the combined subscale score of distance and stair of 75.5 or more identified high performers (sensitivity 0.41, specificity 0.90). We conclude that WIQ cut-offs appropriately classify walking performance in PAD patients, making this a potentially useful clinical tool. Consideration needs to be given to incorporating a standardized WIQ version into practice guidelines and the use of innovative strategies to facilitate clinical uptake. |
format | Online Article Text |
id | pubmed-3419442 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-34194422012-08-23 Further Clinical Validation of the Walking Impairment Questionnaire for Classification of Walking Performance in Patients with Peripheral Artery Disease Sagar, S. P. Brown, P. M. Zelt, D. T. Pickett, W. L. Tranmer, J. E. Int J Vasc Med Research Article The purpose of this study was to further validate the Walking Impairment Questionnaire (WIQ) as a self-report tool to aid in the clinical identification of walking ability of patients with peripheral artery disease (PAD). 132 patients with PAD and an ankle brachial index (ABI) ≤0.90 were enrolled; 123 provided complete data for the WIQ and standardized graded treadmill test. The WIQ scores were consistent with reported scores in other studies. The absolute claudication distance (ACD) ranged from 42.3 to 1589.2 meters; the peak walking time (PWT) ranged from 68 to 1800 seconds. Adjusted WIQ scores were positively and moderately associated with the log transformed ACD and PWT (r > .53, P < .001). Based on the area under the curve analysis, an overall WIQ score of 42.5 or less identified low performers (sensitivity 0.90, specificity 0.73); the combined subscale score of distance and stair of 75.5 or more identified high performers (sensitivity 0.41, specificity 0.90). We conclude that WIQ cut-offs appropriately classify walking performance in PAD patients, making this a potentially useful clinical tool. Consideration needs to be given to incorporating a standardized WIQ version into practice guidelines and the use of innovative strategies to facilitate clinical uptake. Hindawi Publishing Corporation 2012 2012-08-02 /pmc/articles/PMC3419442/ /pubmed/22919494 http://dx.doi.org/10.1155/2012/190641 Text en Copyright © 2012 S. P. Sagar et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Sagar, S. P. Brown, P. M. Zelt, D. T. Pickett, W. L. Tranmer, J. E. Further Clinical Validation of the Walking Impairment Questionnaire for Classification of Walking Performance in Patients with Peripheral Artery Disease |
title | Further Clinical Validation of the Walking Impairment Questionnaire for Classification of Walking Performance in Patients with Peripheral Artery Disease |
title_full | Further Clinical Validation of the Walking Impairment Questionnaire for Classification of Walking Performance in Patients with Peripheral Artery Disease |
title_fullStr | Further Clinical Validation of the Walking Impairment Questionnaire for Classification of Walking Performance in Patients with Peripheral Artery Disease |
title_full_unstemmed | Further Clinical Validation of the Walking Impairment Questionnaire for Classification of Walking Performance in Patients with Peripheral Artery Disease |
title_short | Further Clinical Validation of the Walking Impairment Questionnaire for Classification of Walking Performance in Patients with Peripheral Artery Disease |
title_sort | further clinical validation of the walking impairment questionnaire for classification of walking performance in patients with peripheral artery disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419442/ https://www.ncbi.nlm.nih.gov/pubmed/22919494 http://dx.doi.org/10.1155/2012/190641 |
work_keys_str_mv | AT sagarsp furtherclinicalvalidationofthewalkingimpairmentquestionnaireforclassificationofwalkingperformanceinpatientswithperipheralarterydisease AT brownpm furtherclinicalvalidationofthewalkingimpairmentquestionnaireforclassificationofwalkingperformanceinpatientswithperipheralarterydisease AT zeltdt furtherclinicalvalidationofthewalkingimpairmentquestionnaireforclassificationofwalkingperformanceinpatientswithperipheralarterydisease AT pickettwl furtherclinicalvalidationofthewalkingimpairmentquestionnaireforclassificationofwalkingperformanceinpatientswithperipheralarterydisease AT tranmerje furtherclinicalvalidationofthewalkingimpairmentquestionnaireforclassificationofwalkingperformanceinpatientswithperipheralarterydisease |